EGFR and neoplasm: Sequential regulations of tumor microenvironment by thalidomide and pre‐photodynamic therapy (pre‐PDT) treatments are exploited to achieve synergistic enhancements of tumor accumulation and cancer cell accessibility of epidermal growth factor receptor (EGFR)‐targeted micelle, thereby improve the targeting ability and therapeutic outcome of the active‐targeted nanoparticles.